Clearpoint Neuro, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US18507C1036
USD
17.77
0.96 (5.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Bioventus, Inc.
Sight Sciences, Inc.
Inogen, Inc.
Xtant Medical Holdings, Inc.
Stereotaxis, Inc.
Semler Scientific, Inc.
Clearpoint Neuro, Inc.
TELA Bio, Inc.
Harvard Bioscience, Inc.
Celcuity, Inc.
Jin Medical International Ltd.

Why is Clearpoint Neuro, Inc. ?

1
Negative results in Mar 26
  • OPERATING CASH FLOW(Y) Lowest at USD -25.72 MM
  • ROCE(HY) Lowest at -149.72%
  • DEBT-EQUITY RATIO (HY) Highest at 148.59 %
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 57.96%, its profits have fallen by -35.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Clearpoint Neuro, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Clearpoint Neuro, Inc.
57.96%
2.01
104.01%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
23.57%
EBIT Growth (5y)
-213.51%
EBIT to Interest (avg)
-16.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.84
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
55.85%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.60
EV to EBIT
-11.29
EV to EBITDA
-12.45
EV to Capital Employed
8.56
EV to Sales
7.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-75.83%
ROE (Latest)
-91.15%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
NET PROFIT(HY)

Higher at USD -17.34 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.05 times

RAW MATERIAL COST(Y)

Fallen by -2.96% (YoY

NET SALES(Q)

Highest at USD 12.13 MM

-31What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -25.72 MM

ROCE(HY)

Lowest at -149.72%

DEBT-EQUITY RATIO (HY)

Highest at 148.59 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.85 times

INTEREST(Q)

Highest at USD 1.38 MM

OPERATING PROFIT(Q)

Lowest at USD -7.37 MM

PRE-TAX PROFIT(Q)

Lowest at USD -9.54 MM

NET PROFIT(Q)

Lowest at USD -9.55 MM

EPS(Q)

Lowest at USD -0.32

Here's what is working for Clearpoint Neuro, Inc.

Inventory Turnover Ratio
Highest at 2.05 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
Highest at USD 12.13 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 12.13 MM has Grown at 31.22%
over average net sales of the previous four periods of USD 9.24 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost
Fallen by -2.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 1.11 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 1.11 MM has Grown at 30.79%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for Clearpoint Neuro, Inc.

Pre-Tax Profit
At USD -9.54 MM has Fallen at -49.8%
over average net sales of the previous four periods of USD -6.37 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -9.55 MM has Fallen at -49.6%
over average net sales of the previous four periods of USD -6.39 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
At USD 1.38 MM has Grown at 96.59%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at 148.59 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at USD -25.72 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest
Highest at USD 1.38 MM
in the last five periods and Increased by 96.59% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit
Lowest at USD -7.37 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -9.54 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -9.55 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.32
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Lowest at 5.85 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio